2025 Updates in Hematology and Oncology, Houston
The CME-accredited 2025 Updates in Hematology and Oncology Conference – Houston is designed to enhance cancer care by equipping healthcare professionals with the latest knowledge and advancements in the field. Through case-based presentations, expert-led didactic lectures, and interactive Q&A sessions, this conference will deliver a comprehensive review of recent breakthroughs in hematology and oncology. Our esteemed faculty will translate emerging data into practical insights, highlighting how new evidence may reshape current standards of care. Tailored for physicians, physician assistants, nurse practitioners, pharmacists, nurses, and other cancer care professionals, the program emphasizes a multidisciplinary, patient-centered approach to integrating cutting-edge science into everyday practice.
Target Audience
- Medical oncologists
- Radiation oncologists
- Surgical oncologists
- Oncology residents/fellows
- Oncology NPs/PAs
- Oncology pharmacists
- Oncology nurses
Organizing Committee:
Course Director:
- Binay Shah, MD, MHA - Binaytara
Co-Chairs:
- Julie Nangia, MD - Baylor College of Medicine
- Shilpan Shah, MD - Houston Methodist
Learning Objectives
At the conclusion of this activity, participants will be able to:
- Discuss new and emerging treatment strategies for patients with hematologic malignancies and solid tumors.
- Evaluate the clinical evidence supporting recent advancements in cancer diagnostics and therapeutics.
- Identify indications, contraindications, and common adverse effects of current and novel cancer therapies.
- Implement best practices for managing treatment-related toxicities and improving patient quality of life.
- Integrate multidisciplinary approaches to optimize individualized, evidence-based cancer care.
DAY 1 - SATURDAY, JULY 26, 2025
All times below are listed in Central Daylight Time (CDT)
07:00 AM – 08:00 AM Registration, Breakfast, and Exhibits
08:00 AM – 08:05 AM Welcome
08:05 AM – 09:35 AM Session 1 - Hematologic Malignancies
Session Chair: Shilpan Shah, MD
08:05 AM – 08:35 AM MDS/Leukemias/CLL - Nitin Jain, MD; Shilpan Shah, MD
08:35 AM – 09:05 AM Multiple Myeloma - Martha Pritchett Mims, MD, PhD
09:05 AM – 09:35 AM Lymphoma - Praveen Ramakrishnan Geethakumari, MD
09:35 AM – 09:45 AM Break and Exhibits
09:45 AM – 11:05 AM Session 2 - General Oncology
Session Chair: Tracilyn Rachelle Hall, MD
09:45 AM – 10:15 AM Sarcoma - Neeta Somaiah, MD
10:05 AM – 10:45 AM Cutaneous Malignancies - Isabella C. Glitza Oliva, MD, PhD, MS
10:45 AM – 11:05 AM Gynecologic - Tracilyn Rachelle Hall, MD
11:05 AM – 11:55 AM Session 3 - Tumor- Board Style Case-based Discussion: Challenging Cases
Session Chair: Shilpan Shah, MD
Case-based Discussion: Mathews Roy, MD ; Vikram Dhillon, DO, MBA ; Yuqi Zhang, MD, PhD
Panel Discussion : Sarah Yue Wang, MD, MS ; Tejo N. Musunuru, MD ; Sara Taveras Alam, MD
11:55 AM – 12:15 PM Access to Cancer Care in LMIC - Justine Kam
12:15 PM – 01:15 PM Lunch & Exhibits
01:15 PM – 02:45 PM Session 4 - Genitourinary Cancer
Session Chair: Bilal A Siddiqui, MD
01:15 PM – 01:45 PM Prostate Cancer - Bilal A Siddiqui, MD
01:45 PM – 02:15 PM Bladder Cancer - Catherine Wiechmann , MD
02:15 PM – 02:45 PM Kidney Cancer - Patrick Prath, MD
02:45 PM – 03:15 PM Break and Exhibits
03:15 PM – 04:45 PM Session 5 - Gastrointestinal Cancer
Session Chair: Shalini U Makawita, MD, MSc
03:15 PM – 03:45 PM Upper GI Cancer - Karen Riggins, MD, PhD
03:45 PM – 04:15 PM Hepatobiliary and Pancreatic Malignancies - Sunyoung S. Lee, MD, PhD
04:15 PM – 04:45 PM Colorectal Cancer - Shalini U Makawita, MD, MSc
04:45 PM – 05:15 PM Reception and Networking
DAY 2 - SUNDAY, JULY 27, 2025
07:00 AM – 08:00 AM Registration, Breakfast, and Exhibits
08:00 AM – 09:30 AM Session 6 - Breast Cancer
Session Chair: Michelina Cairo, MD
08:00 AM – 08:30 AM Hormone Receptor Positive Breast Cancer - Ahmed Elkhanany, MD
08:30 AM – 09:00 AM Triple Negative Breast Cancer - Akshjot Puri, MD
09:00 AM – 09:30 AM HER2-Positive Breast Cancer - Polly Niravath MD
09:30 AM – 10:15 AM Session 7 - Tumor-Board Style Discussion: Challenging Cases
Session Chair: Quillan Huang, MD
Case Based Discussion : Justin Komisarof MD, PhD
Panel Discussion : Quillan Huang, MD; Syed H. Jafri, MBBS ; Devesh Pandya, MD
10:15 AM – 10:30 AM Break and Exhibits
10:30 AM – 12:00 PM Session 8 - Thoracic Oncology
Session Chair: Jun Zhang, MD
10:30 AM – 11:00 AM Early-Stage Non-Small Cell Lung Cancer - Jian Guan, MD, PhD
11:00 AM – 11:30 AM Metastatic Non-Small Cell Lung Cancer - Jianjun Zhang, MD, PhD
11:30 AM – 12:00 PM Small Cell Lung Cancer - Meera Patel, MD, MHS
12:00 PM Adjourn
IDENTIFICATION AND MITIGATION OF POTENTIAL CONFLICT OF INTERESTS:
All conflict of interest has been identified and mitigated for individuals in control of contents.
PLANNING COMMITTEE DISCLOSURE STATEMENT:
None of the members of the planning committee, nor any member of their immediate families, have a relevant financial interest in or affiliation with any commercial supporter of this educational activity and/or with the manufacturer(s) of commercial products and/or providers of any commercial services discussed in this educational activity.
Michelina Cairo, MD
Quillan Huang, MD
Jun Zhang, MD
Ahmed Elkhanany, MD
Isabella Glitza Oliva
Jian Guan
Tracilyn Hall, Associate Professor of Gynecologic Oncology
Nitin Jain, MD
Sunyoung Lee, MD, PhD
Shalini Makawita
Martha Mims
Polly Niravath, MD
Meera Patel, MD, MHS
Patrick Prath, MD
Akshjot Puri, MD
Praveen Ramakrishnan Geethakumari, MD, MS, MBA, FACP
Karen Riggins
Bilal Siddiqui, MD
Neeta Somaiah, MD
Catherine Wiechmann
Jianjun Zhang, MD, PhD
Vikram Dhillon, DO, MBA
Syed Jafri
Justin Komisarof, MD/PhD
Tejo Musunuru, MD
Devesh Pandya
Mathews Roy, MD
Sara Taveras Alam
Sarah Wang, MD
Yuqi Zhang, MD, PhD
Available Credit
- 10.50 ABIM MOC IISuccessful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 10.50 Medical Knowledge points in the American Board of Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
- 10.50 ACPE Pharmacy
The Binaytara is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
The ACPE Universal Activity Number assigned to the activity is 0686-0000-25-030-L01-P
Participants must pass the post-test, complete course evaluation, and provide their NABP e-Profile ID number (ePID) and Date of Birth (MMDD) to Binaytara Foundation within 30-days of participating in the activity. Participants who do not complete these requirements within 30-days of participating in the Live activity will not be awarded the CEUs.
The Binaytara may distribute a participation certificate containing information provided to NABP from the Accreditation Council for Pharmacy Education (ACPE) via CPE Monitor®. ACPE policy states paper and/or electronic statements of credit may no longer be distributed directly to learners as proof of ACPE credit. The official record of credit may be located in the learner’s e-profile in CPE Monitor®.
After CPE units are processed by ACPE and NABP, pharmacists and pharmacy technicians will be able to login to a comprehensive electronic profile to access information about their completed CPE and Certificate Programs.
- 10.50 AMA PRA Category 1 Credit™
The Binaytara is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara designates this live activity for a maximum of 10.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 10.50 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
- 10.50 Nursing Contact HoursProvider approved by the California Board of Registered Nursing, Provider # CEP17035, for 10.50 Contact Hours.
If you are interested in exhibiting at this meeting or purchasing a badge with your company at our discounted rate for exhibitors, please visit our exhibit page here - https://www.sponsorships.binaytara.org/HoustonHemeOnc
Price
POLICY ON INDUSTRY EMPLOYEE'S PARTICIPATION IN MARKETING/EDUCATION ACTIVITY AT THE CONFERENCE:
All marketing and product promotion activities must occur in the designated exhibit hall or product theater space separate from the area where this accredited continuing education takes place.
The exhibit and product promotion space is reserved only for companies that have purchased marketing and product promotion slots at the conference. The individual registration fee doesn't include marketing or product theater privileges. Please refer to the sponsorship handbook for the types of marketing activities included in your display/sponsorship fees.
If your company has NOT purchased a marketing opportunity such as an exhibit table, product theater slot or another type of marketing opportunity, you may not participate in any marketing activity or attempt to educate healthcare providers about your product or service. Industry attendees of companies without marketing opportunities must refrain from interacting with healthcare providers at this meeting in any form, including introducing themselves as an employee of the company, discussing the care of patients, handing out flyers and brochures, inviting participants to the company's other programs, etc.
Violating this policy will result in a fine equivalent to a general display fee for that conference.
NOTICE TO HCPS EMPLOYED BY THE INDUSTRY:
If you are employed by industry, including pharmaceuticals and biotech companies, you must pay the INDUSTRY REGISTRATION FEE to participate in any meeting organized by the Binaytara Foundation. If you misrepresented yourself as a healthcare provider not employed by the industry and failed to pay the Industry registration fee, the following fees apply:
- If your company has purchased a display table at the event, you will be billed the full INDUSTRY REGISTRATION FEE plus a fine equivalent to the full industry registration fee for that event = 2 X the industry registration fee.
- If your company has NOT purchased a display table at the event AND you attended the meeting without paying a full industry registration fee, you will be billed a full GENERAL DISPLAY FEE for that event.
- If your company has NOT purchased a display table at the event AND you attended the meeting paying a full industry registration fee, BUT YOU PARTICIPATED IN MARKETING AND PROMOTIONAL ACTIVITIES, you will be billed a full GENERAL DISPLAY FEE for that event.
Any outstanding display fee, registration fee, and fines must be paid before the industry employee or the company will be able to attend/display at our conferences again.
CANCELLATION POLICY
You may cancel your enrollment at any time. Cancellation fees apply as below:
- 50% of the paid registration fee will be refunded if registration is canceled six weeks before the conference.
- No refunds will be issued if registration is canceled after that date.
No credits will be offered if you do not complete all required steps of this activity, including registration and participation in the live meeting.